SEC Form 4 · accession 0000899243-19-000526
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin D. Gover
Officer — Chief Executive Officer · Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jan 2, 2019 | S | 2,400 | $7.96 | D | 413,285 | D | |
| Ordinary SharesF1,F3 | Jan 2, 2019 | S | 3,600 | $8.14 | D | 409,685 | D | |
| Ordinary SharesF1,F4 | Jan 2, 2019 | S | 1,200 | $8.25 | D | 408,485 | D | |
| Ordinary SharesF1,F5 | Jan 2, 2019 | S | 14,220 | $8.43 | D | 394,265 | D | |
| Ordinary SharesF1,F6 | Jan 2, 2019 | S | 1,200 | $8.52 | D | 393,065 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F2The price reported in Column 4 is price per ordinary share ($95.51 per ADS).
- F3The price reported in Column 4 is a weighted average price per ordinary share ($97.69 per ADS). These shares were sold in multiple transactions at prices ranging from $97.14 per ADS (or $8.10 per ordinary share) to $97.97 per ADS (or $8.16 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4The price reported in Column 4 is price per ordinary share ($99.00 per ADS).
- F5The price reported in Column 4 is a weighted average price per ordinary share ($101.13 per ADS). These shares were sold in multiple transactions at prices ranging from $100.64 per ADS (or $8.39 per ordinary share) to $101.63 per ADS (or $8.47 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F6The price reported in Column 4 is price per ordinary share ($102.25 per ADS).